Impact of Donor Hepatitis C Virus Infection Status on Death and Need for Liver Transplant in Hepatitis C Virus-Positive Kidney Transplant Recipients

被引:35
|
作者
Kucirka, Lauren M. [1 ]
Peters, Thomas G. [2 ]
Segev, Dorry L. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA
[3] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
Hepatitis C; kidney transplant; liver transplant; competing risks; RENAL-TRANSPLANTATION; SURVIVAL; DIALYSIS; RISK;
D O I
10.1053/j.ajkd.2012.03.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Only 29% of deceased donor kidney recipients with hepatitis C virus (HCV) receive HCV-positive (HCV+) kidneys. These kidneys are discarded 2.5 times more often than their HCV-negative (HCV-) counterparts, possibly due to the sense that an HCV+ kidney may adversely affect recipient liver function. The goals of this study were to characterize liver disease in HCV+ kidney recipients and compare rates of liver-related outcomes by kidney donor HCV status. Study Design: Observational cohort study. Setting & Participants: 6,250 patients with HCV who had a kidney transplant in 1995-2008 as captured in the United Network for Organ Sharing (UNOS) database. Liver-related outcomes were assessed by cross-linking with the liver waitlist and transplant data sets. Predictor: HCV status of transplanted kidney. Outcomes: Joining the liver waitlist, receiving a liver transplant, death. Measurements: Time to event. Results: Only 63 (1%) of HCV+ kidney recipients eventually joined the liver waitlist during the 13-year study period. Those who received HCV+ kidneys had a 2.6-fold higher hazard of joining the liver list (P < 0.001); however, the absolute difference in rate of listing between recipients of HCV- and HCV+ kidneys was <2%. This is consistent with findings of only 2% lower patient survival at 3 years in HCV+ patients receiving HCV+ versus HCV- kidneys. Limitations: We lacked data for HCV viral load and genotype of both HCV+ recipients and transplanted HCV+ kidneys. Conclusions: Because transplant with an HCV+ kidney may reduce waiting-time by more than a year for an HCV+ patient and there is a high risk of kidney waitlist mortality, a 2% increased rate of adverse liver outcomes and 2% increased rate of death at 3 years should not universally preclude the use of HCV+ kidneys when the intended recipient is also HCV+. Am J Kidney Dis. 60(1):112-120. (C) 2012 by the National Kidney Foundation, Inc.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 50 条
  • [41] Progression of Hepatic Histopathology in Kidney Transplant Recipients With Chronic Hepatitis C Virus Infection and Effect of Immunosuppression on the Course of Hepatitis C Virus Infection
    Korkmaz, Murat
    Faki, Sevgul
    Ocal, Serkan
    Harmanci, Ozgur
    Selcuk, Haldun
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 : 159 - 164
  • [42] The corrected donor age for hepatitis C virus-infected liver transplant recipients
    Dirchwolf, Melisa
    Dodge, Jennifer L.
    Gralla, Jane
    Bambha, Kiran M.
    Nydam, Trevor
    Hung, Kenneth W.
    Rosen, Hugo R.
    Feng, Sandy
    Terrault, Norah A.
    Biggins, Scott W.
    LIVER TRANSPLANTATION, 2015, 21 (08) : 1022 - 1030
  • [43] Donor Risk Index for African American Liver Transplant Recipients With Hepatitis C Virus
    Shores, Nathan J.
    Dodge, Jennifer L.
    Feng, Sandy
    Terrault, Norah A.
    HEPATOLOGY, 2013, 58 (04) : 1263 - 1269
  • [44] Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients
    Vargas, HE
    Laskus, T
    Radkowski, M
    Poutous, A
    Wang, LF
    Lee, R
    Dodson, F
    Gayowski, T
    Singh, N
    Marino, IR
    Fung, JJ
    ZhangKeck, ZY
    Kim, JP
    Rakela, J
    TRANSPLANTATION, 1997, 64 (05) : 786 - 788
  • [45] The impact of donor hepatitis B virus infection on transplant outcomes in deceased donor kidney transplantation recipients
    Luo, You
    Zhang, Rui
    Hu, Xiao
    Tang, Zuofu
    Zhang, Jinhua
    Wu, Jiaqing
    Na, Ning
    Xiao, Hengjun
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2025, 44 (02) : 361 - 375
  • [46] The Use of Hepatitis C Virus-Positive Organs in Hepatitis C Virus-Negative Recipients
    Kuntzen, Christian
    Bagha, Zohaib
    CLINICS IN LIVER DISEASE, 2022, 26 (02) : 291 - 312
  • [47] Usefulness of Liver Biopsy in Anti-Hepatitis C Virus Antibody-Positive and Hepatitis C Virus RNA-Negative Kidney Transplant Recipients
    Kim, So Mi
    Kim, Hyeon Woo
    Lee, Eun-kyoung
    Park, Su Kil
    Han, Duck Jong
    Kim, Soon Bae
    TRANSPLANTATION, 2013, 96 (01) : 85 - 90
  • [48] Hepatitis G virus infection in liver transplant recipients
    Fischer, L
    Sterneck, M
    Feucht, HH
    Schuhmacher, C
    Malagó, M
    Rogiers, X
    Laufs, R
    Broelsch, CE
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 496 - 499
  • [49] HEPATITIS-C VIRUS-INFECTION AMONG KIDNEY-TRANSPLANT RECIPIENTS
    PONZ, E
    CAMPISTOL, JM
    TORREGROSA, JV
    BARRERA, JM
    GIL, C
    OPPENHEIMER, F
    ANDREU, J
    BRUGUERA, M
    NEFROLOGIA, 1993, 13 (05): : 460 - 466
  • [50] HEPATITIS-C VIRUS-INFECTION AMONG KIDNEY-TRANSPLANT RECIPIENTS
    PONZ, E
    CAMPISTOL, JM
    BRUGUERA, M
    BARRERA, JM
    GIL, C
    PINTO, JB
    ANDREU, J
    KIDNEY INTERNATIONAL, 1991, 40 (04) : 748 - 751